Question · asked by 1 review
Aspirin plus antipsychotics vs placebo/no adjunctive treatment + antipsychotics: Quality of life: clinically important change in quality of life
- Population
- patients with schizophrenia
- Intervention
- Aspirin plus antipsychotics
- Comparison
- placebo/no adjunctive treatment + antipsychotics
- Outcome
- Quality of life: clinically important change in quality of life
The review found no eligible studies for this question.
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Aspirin plus antipsychotics vs placebo plus antipsychotics Quality of life: clinically important change · people with schizophrenia The review found no eligible studies for this question. Acetylsalicylic acid (aspirin) for schizophrenia (2019) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Acetylsalicylic acid (aspirin) for schizophrenia 2019 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.